Mersana Therapeutics saw no growth in patent filings and highest growth of 0.66% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.66%. GlobalData’s DataBook provides a comprehensive analysis of Mersana Therapeutics‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Mersana Therapeutics has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 100% filings and 67% grants. The United States(US), and Israel(IL) patent Office are among the top ten patent offices where Mersana Therapeutics is filings its patents. Among the top granted patent authorities, Mersana Therapeutics has 67% of its grants in United States(US) and 33% in Israel(IL).
Roche could be the strongest competitor for Mersana Therapeutics
Patents related to rare diseases lead Mersana Therapeutics's portfolio
Mersana Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
Breast cancer related patents lead Mersana Therapeutics portfolio followed by ovarian cancer, and non-small cell lung cancer
Mersana Therapeutics has highest number of patents in breast cancer followed by ovarian cancer, non-small cell lung cancer, gastric cancer, and kidney cancer (renal cell cancer). For breast cancer, nearly 10% of patents were filed and 8% of patents were granted in Q2 2024.
For comprehensive analysis of Mersana Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
